These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39187773)

  • 1. APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis.
    Fan Z; Liu Y; Wang X; Xu Y; Huang R; Shi W; Qu Y; Ruan J; Zhou C; Zhao X; Liu L
    BMC Cancer; 2024 Aug; 24(1):1046. PubMed ID: 39187773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition.
    Lyu Q; Lin A; Cao M; Xu A; Luo P; Zhang J
    Cancer Control; 2020; 27(1):1073274820976665. PubMed ID: 33356494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy.
    Chen Z; Hu J; Ou Y; Ye F; Li W; Liu S; Jiang H
    Front Immunol; 2024; 15():1427124. PubMed ID: 39238647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer.
    Zhang X; Hong B; Li H; Zhao J; Li M; Wei D; Wang Y; Zhang N
    BMC Cancer; 2024 Jun; 24(1):746. PubMed ID: 38898429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.
    Chen D; Cao H; Zheng X; Wang H; Han Z; Wang W
    BMC Cancer; 2024 Aug; 24(1):1024. PubMed ID: 39160525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
    Wu P; Zhao L; Kong G; Song B
    Technol Cancer Res Treat; 2024; 23():15330338241246649. PubMed ID: 38656249
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
    Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.
    Huang Z; Wang Z; Xu C; Yan Y; Cao X; Zhang F; Shen B
    Int J Med Sci; 2024; 21(8):1447-1460. PubMed ID: 38903931
    [No Abstract]   [Full Text] [Related]  

  • 10. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.
    Liu R; Yang T; Huang J; Xiao Z; Liu J; Li Z; Tong S
    BMC Cancer; 2024 Aug; 24(1):947. PubMed ID: 39095785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
    Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
    Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment.
    Ma J; Hu J; Zhao L; Wu Z; Li R; Deng W
    BMC Urol; 2024 Jan; 24(1):6. PubMed ID: 38172792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer.
    Liu X; Qiu Z; Zhang X; Su Z; Yi R; Zou D; Xie C; Jin N; Long W; Liu X
    Environ Toxicol; 2024 Feb; 39(2):680-694. PubMed ID: 37647346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA).
    Cao R; Ma B; Wang G; Xiong Y; Tian Y; Yuan L
    J Cell Mol Med; 2021 Jun; 25(12):5417-5433. PubMed ID: 33960661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.
    Li H; Zu X; Hu J; Xiao Z; Cai Z; Gao N; Chen J
    Front Immunol; 2022; 13():964393. PubMed ID: 36211344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common immunological and prognostic features of lung and bladder cancer via smoking-related genes: PRR11 gene as potential immunotherapeutic target.
    Wang Y; Zhu H; Zhang L; He J; Bo J; Wang J; Ding B; Ren M
    J Cell Mol Med; 2024 May; 28(10):e18384. PubMed ID: 38760964
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhao X; Hu J; Li J; Gu L; Chen J; Othmane B; Gong G; Yuan J; Deng H
    Dis Markers; 2022; 2022():7147279. PubMed ID: 35909893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.
    Liu Z; Qi T; Li X; Yao Y; Othmane B; Chen J; Zu X; Ou Z; Hu J
    Front Immunol; 2021; 12():791924. PubMed ID: 34975891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
    Yan Z; Liu Y; Wang M; Wang L; Chen Z; Liu X
    Sci Rep; 2024 Jun; 14(1):14667. PubMed ID: 38918587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.